☰

Eliot M. Rosen

Affiliations: 
Biochemistry & Molecular Georgetown University, Washington, DC 
Area:
Biochemistry, Cell Biology
Google:
"Eliot Rosen"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Rahul D. Ballal grad student 2010 Georgetown
Tejaswita M. Karve grad student 2012 Georgetown

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nathan S, Ma Y, Tomita YA, et al. (2017) BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells. Breast Cancer Research and Treatment
Nathan S, Rosen EM. (2017) Abstract 3602: Novel BRCA1 mimetic 35446HCl inhibits growth of anti estrogen resistant breast cancer cells through the NF-κB pathway Cancer Research. 77: 3602-3602
Ma Y, Preet A, Tomita Y, et al. (2015) A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance. Oncotarget
Ma Y, Tomita Y, Preet A, et al. (2014) Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α. Molecular Endocrinology (Baltimore, Md.). 28: 1971-86
Rosen EM, Pishvaian MJ. (2014) Targeting the BRCA1/2 tumor suppressors. Current Drug Targets. 15: 17-31
Xu JY, Meng QH, Chong Y, et al. (2013) Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration. Molecular and Clinical Oncology. 1: 331-336
Fan S, Meng Q, Xu J, et al. (2013) DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism. Proceedings of the National Academy of Sciences of the United States of America. 110: 18650-5
Rosen EM. (2013) BRCA1 in the DNA damage response and at telomeres. Frontiers in Genetics. 4: 85
Ma Y, Preet A, Hu C, et al. (2013) Abstract 5574: Development of novel breast cancer therapeutics for anti-estrogen resistant breast cancer. Cancer Research. 73: 5574-5574
Oliveira EOD, Ma Y, Tomita Y, et al. (2013) Abstract 2458: Discovery and development of novel 4-aminopyrimidines (A9 analogs) as potential BRCA1-mimetic drugs for the treatment of breast cancer. Cancer Research. 73: 2458-2458
See more...